0.012623
0.007288
0.000000
0.000000
0.014576
0.000000
0.000000
0.000000
0.027112
0.00000
0.00000
0.00000
Wan, Z.
Zhao, M.
Nakagawa, S.
Jia, W.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
18
90.00
90.00
120.00
79.220
79.220
36.884
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C4 H10 N2 O2
118.134
n
2,4-DIAMINOBUTYRIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
Zn 2
65.409
ZINC ION
non-polymer
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
315
103
111
10.1006/jmbi.2001.5224
11779231
Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
2002
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
97
1999
2004
10.1073/pnas.97.5.1999
Diabetes-associated mutations in a beta-cell transcription factor destabilize an antiparallel "mini-zipper" in a dimerization interface
2000
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
284
477
488
10.1006/jmbi.1998.2175
The Relationship Between Insulin Bioactivity and Structure in the NH2-terminal A-chain Helix
1998
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
264
390
403
10.1006/jmbi.1996.0648
Mapping the Functional Surface of Insulin by Design: Structure and Function of a Novel A-chain Analogue
1996
NE
Biophys.Chem.
BICIAZ
0829
0301-4622
50
63
71
10.1016/0301-4622(94)85020-8
A Proposed Interaction Model of the Insulin Molecule with its Receptor
1994
10.2210/pdb1j73/pdb
pdb_00001j73
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
mirrors
IMAGE PLATE
1998-04-26
RIGAKU RAXIS II
Mirrors
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RU200
2382.713
insulin a
T8(DAB)
2
syn
polymer
3433.953
insulin b
2
syn
polymer
65.409
ZINC ION
2
syn
non-polymer
18.015
water
95
nat
water
no
yes
GIVEQCC(DAB)SICSLYQLENYCN
GIVEQCCASICSLYQLENYCN
A,C
polypeptide(L)
no
no
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
B,D
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
1.91
35.75
VAPOR DIFFUSION, HANGING DROP
6.4
Tris, phonel, acetone, sodium citrate, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
298
database_2
struct_conn
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Derived calculations
Version format compliance
Database references
Derived calculations
1
0
2001-05-30
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_conn.conn_type_id
_struct_conn.id
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_asym_id
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_asym_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr1_symmetry
_struct_conn.ptnr2_auth_asym_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_conn.ptnr2_symmetry
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
1TRZ contains the same sequence and structure,
without substitution of Thr-A8 by diaminobutyric acid
COMPOUND
THE CONFORMATIONS OF TWO MONOMERS ARE DIFFERENT AS THE
RESULT OF A CHANGE IN CONFORMATION OF THE FIRST EIGHT
RESIDUES OF THE B-CHAINS.
RCSB
Y
RCSB
2001-05-15
REL
ZN
ZINC ION
HOH
water
The protein was chemically synthesized. The sequence is naturally found in Homo sapiens(human).
sample
The protein was chemically synthesized. The sequence is naturally found in Homo sapiens(human).
sample
ZN
1
3
ZN
ZN
31
B
ZN
2
3
ZN
ZN
31
D
HOH
3
4
HOH
HOH
22
A
HOH
5
4
HOH
HOH
23
A
HOH
12
4
HOH
HOH
24
A
HOH
15
4
HOH
HOH
25
A
HOH
16
4
HOH
HOH
26
A
HOH
20
4
HOH
HOH
27
A
HOH
35
4
HOH
HOH
28
A
HOH
38
4
HOH
HOH
29
A
HOH
39
4
HOH
HOH
30
A
HOH
41
4
HOH
HOH
31
A
HOH
44
4
HOH
HOH
32
A
HOH
45
4
HOH
HOH
33
A
HOH
47
4
HOH
HOH
34
A
HOH
52
4
HOH
HOH
35
A
HOH
60
4
HOH
HOH
36
A
HOH
66
4
HOH
HOH
37
A
HOH
68
4
HOH
HOH
38
A
HOH
70
4
HOH
HOH
39
A
HOH
76
4
HOH
HOH
40
A
HOH
77
4
HOH
HOH
41
A
HOH
80
4
HOH
HOH
42
A
HOH
83
4
HOH
HOH
43
A
HOH
86
4
HOH
HOH
44
A
HOH
87
4
HOH
HOH
45
A
HOH
89
4
HOH
HOH
46
A
HOH
6
4
HOH
HOH
32
B
HOH
7
4
HOH
HOH
33
B
HOH
8
4
HOH
HOH
34
B
HOH
9
4
HOH
HOH
35
B
HOH
11
4
HOH
HOH
36
B
HOH
17
4
HOH
HOH
37
B
HOH
19
4
HOH
HOH
38
B
HOH
22
4
HOH
HOH
39
B
HOH
24
4
HOH
HOH
40
B
HOH
27
4
HOH
HOH
41
B
HOH
34
4
HOH
HOH
42
B
HOH
36
4
HOH
HOH
43
B
HOH
37
4
HOH
HOH
44
B
HOH
40
4
HOH
HOH
45
B
HOH
43
4
HOH
HOH
46
B
HOH
46
4
HOH
HOH
47
B
HOH
49
4
HOH
HOH
48
B
HOH
51
4
HOH
HOH
49
B
HOH
53
4
HOH
HOH
50
B
HOH
55
4
HOH
HOH
51
B
HOH
59
4
HOH
HOH
52
B
HOH
62
4
HOH
HOH
53
B
HOH
63
4
HOH
HOH
54
B
HOH
64
4
HOH
HOH
55
B
HOH
71
4
HOH
HOH
56
B
HOH
74
4
HOH
HOH
57
B
HOH
75
4
HOH
HOH
58
B
HOH
78
4
HOH
HOH
59
B
HOH
79
4
HOH
HOH
60
B
HOH
82
4
HOH
HOH
61
B
HOH
84
4
HOH
HOH
62
B
HOH
88
4
HOH
HOH
63
B
HOH
90
4
HOH
HOH
64
B
HOH
4
4
HOH
HOH
22
C
HOH
13
4
HOH
HOH
23
C
HOH
14
4
HOH
HOH
24
C
HOH
21
4
HOH
HOH
25
C
HOH
25
4
HOH
HOH
26
C
HOH
26
4
HOH
HOH
27
C
HOH
28
4
HOH
HOH
28
C
HOH
30
4
HOH
HOH
29
C
HOH
31
4
HOH
HOH
30
C
HOH
33
4
HOH
HOH
31
C
HOH
42
4
HOH
HOH
32
C
HOH
50
4
HOH
HOH
33
C
HOH
56
4
HOH
HOH
34
C
HOH
57
4
HOH
HOH
35
C
HOH
65
4
HOH
HOH
36
C
HOH
72
4
HOH
HOH
37
C
HOH
73
4
HOH
HOH
38
C
HOH
85
4
HOH
HOH
39
C
HOH
91
4
HOH
HOH
40
C
HOH
92
4
HOH
HOH
41
C
HOH
93
4
HOH
HOH
42
C
HOH
94
4
HOH
HOH
43
C
HOH
95
4
HOH
HOH
44
C
HOH
10
4
HOH
HOH
32
D
HOH
18
4
HOH
HOH
33
D
HOH
23
4
HOH
HOH
34
D
HOH
29
4
HOH
HOH
35
D
HOH
32
4
HOH
HOH
36
D
HOH
48
4
HOH
HOH
37
D
HOH
54
4
HOH
HOH
38
D
HOH
58
4
HOH
HOH
39
D
HOH
61
4
HOH
HOH
40
D
HOH
67
4
HOH
HOH
41
D
HOH
69
4
HOH
HOH
42
D
HOH
81
4
HOH
HOH
43
D
HOH
96
4
HOH
HOH
44
D
HOH
97
4
HOH
HOH
45
D
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
DBA
8
n
8
DAB
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
THR
30
n
30
THR
30
B
GLY
1
n
1
GLY
1
C
ILE
2
n
2
ILE
2
C
VAL
3
n
3
VAL
3
C
GLU
4
n
4
GLU
4
C
GLN
5
n
5
GLN
5
C
CYS
6
n
6
CYS
6
C
CYS
7
n
7
CYS
7
C
DBA
8
n
8
DAB
8
C
SER
9
n
9
SER
9
C
ILE
10
n
10
ILE
10
C
CYS
11
n
11
CYS
11
C
SER
12
n
12
SER
12
C
LEU
13
n
13
LEU
13
C
TYR
14
n
14
TYR
14
C
GLN
15
n
15
GLN
15
C
LEU
16
n
16
LEU
16
C
GLU
17
n
17
GLU
17
C
ASN
18
n
18
ASN
18
C
TYR
19
n
19
TYR
19
C
CYS
20
n
20
CYS
20
C
ASN
21
n
21
ASN
21
C
PHE
1
n
1
PHE
1
D
VAL
2
n
2
VAL
2
D
ASN
3
n
3
ASN
3
D
GLN
4
n
4
GLN
4
D
HIS
5
n
5
HIS
5
D
LEU
6
n
6
LEU
6
D
CYS
7
n
7
CYS
7
D
GLY
8
n
8
GLY
8
D
SER
9
n
9
SER
9
D
HIS
10
n
10
HIS
10
D
LEU
11
n
11
LEU
11
D
VAL
12
n
12
VAL
12
D
GLU
13
n
13
GLU
13
D
ALA
14
n
14
ALA
14
D
LEU
15
n
15
LEU
15
D
TYR
16
n
16
TYR
16
D
LEU
17
n
17
LEU
17
D
VAL
18
n
18
VAL
18
D
CYS
19
n
19
CYS
19
D
GLY
20
n
20
GLY
20
D
GLU
21
n
21
GLU
21
D
ARG
22
n
22
ARG
22
D
GLY
23
n
23
GLY
23
D
PHE
24
n
24
PHE
24
D
PHE
25
n
25
PHE
25
D
TYR
26
n
26
TYR
26
D
THR
27
n
27
THR
27
D
PRO
28
n
28
PRO
28
D
LYS
29
n
29
LYS
29
D
THR
30
n
30
THR
30
D
author_and_software_defined_assembly
PISA,PQS
12
dodecameric
17750
-264
14220
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
31
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
2_555
102.9
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
31
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
3_555
102.9
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
31
E
ZN
ZN
1_555
B
HIS
10
B
NE2
HIS
10
3_555
102.9
D
HIS
10
D
NE2
HIS
10
1_555
D
ZN
31
F
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
2_555
108.7
D
HIS
10
D
NE2
HIS
10
1_555
D
ZN
31
F
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
3_555
108.7
D
HIS
10
D
NE2
HIS
10
2_555
D
ZN
31
F
ZN
ZN
1_555
D
HIS
10
D
NE2
HIS
10
3_555
108.7
A
DAB
8
2,4-DIAMINOBUTYRIC ACID
A
DAB
8
ALA
C
DAB
8
2,4-DIAMINOBUTYRIC ACID
C
DAB
8
ALA
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_555
-y,x-y,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
0.8660254038
0.0000000000
-0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
3_555
-x+y,-x,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
B
N
TYR
26
B
N
TYR
26
D
O
PHE
24
D
O
PHE
24
1
B
ZN
31
E
ZN
1
D
ZN
31
F
ZN
1
B
B
NE2
CD2
HIS
HIS
5
5
-0.069
0.011
1.373
1.304
N
1
D
D
NE2
CD2
HIS
HIS
5
5
-0.069
0.011
1.373
1.304
N
1
D
D
NE2
CD2
HIS
HIS
10
10
-0.073
0.011
1.373
1.300
N
0.273
0.205
2.0
10.0
500
5681
5448
9.2
random
1
2.0
1.0
2.0
10.0
95
907
2
0
810
2.0
10.0
1J73
5681
5448
2.0
1.0
0.05
1
3
95.0
0.097
2.0
2.03
1
611
100.0
data reduction
DENZO
data scaling
SCALEPACK
model building
X-PLOR
refinement
X-PLOR
3.1
phasing
X-PLOR
Crystal structure of an unstable insulin analog with native activity.
1
N
N
2
N
N
1
N
N
2
N
N
3
N
N
3
N
N
4
N
N
4
N
N
4
N
N
4
N
N
A
GLY
1
A
GLY
1
HELX_P
A
CYS
7
A
CYS
7
1
1
7
A
SER
12
A
SER
12
HELX_P
A
GLU
17
A
GLU
17
1
2
6
B
GLY
8
B
GLY
8
HELX_P
B
GLY
20
B
GLY
20
1
3
13
B
GLU
21
B
GLU
21
HELX_P
B
GLY
23
B
GLY
23
5
4
3
C
GLY
1
C
GLY
1
HELX_P
C
CYS
7
C
CYS
7
1
5
7
C
SER
12
C
SER
12
HELX_P
C
GLU
17
C
GLU
17
1
6
6
D
ASN
3
D
ASN
3
HELX_P
D
GLY
20
D
GLY
20
1
7
18
D
GLU
21
D
GLU
21
HELX_P
D
GLY
23
D
GLY
23
5
8
3
disulf
2.025
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.003
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.025
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
disulf
2.029
C
CYS
6
C
SG
CYS
6
1_555
C
CYS
11
C
SG
CYS
11
1_555
disulf
2.021
C
CYS
7
C
SG
CYS
7
1_555
D
CYS
7
D
SG
CYS
7
1_555
disulf
2.022
C
CYS
20
C
SG
CYS
20
1_555
D
CYS
19
D
SG
CYS
19
1_555
covale
1.361
both
A
CYS
7
A
C
CYS
7
1_555
A
DAB
8
A
N
DAB
8
1_555
covale
1.338
both
A
DAB
8
A
C
DAB
8
1_555
A
SER
9
A
N
SER
9
1_555
covale
1.328
both
C
CYS
7
C
C
CYS
7
1_555
C
DAB
8
C
N
DAB
8
1_555
covale
1.350
both
C
DAB
8
C
C
DAB
8
1_555
C
SER
9
C
N
SER
9
1_555
metalc
2.169
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
31
E
ZN
ZN
1_555
metalc
2.169
B
HIS
10
B
NE2
HIS
10
2_555
B
ZN
31
E
ZN
ZN
1_555
metalc
2.169
B
HIS
10
B
NE2
HIS
10
3_555
B
ZN
31
E
ZN
ZN
1_555
metalc
2.098
D
HIS
10
D
NE2
HIS
10
1_555
D
ZN
31
F
ZN
ZN
1_555
metalc
2.098
D
HIS
10
D
NE2
HIS
10
2_555
D
ZN
31
F
ZN
ZN
1_555
metalc
2.098
D
HIS
10
D
NE2
HIS
10
3_555
D
ZN
31
F
ZN
ZN
1_555
HORMONE/GROWTH FACTOR
A8-Diaminobutyric Acid human insulin, hormone-receptor interface, HORMONE-GROWTH FACTOR COMPLEX
INS_HUMAN
UNP
1
90
P01308
INS_HUMAN
UNP
2
25
P01308
90
110
1J73
1
21
P01308
A
1
1
21
25
54
1J73
1
30
P01308
B
2
1
30
90
110
1J73
1
21
P01308
C
1
1
21
25
54
1J73
1
30
P01308
D
2
1
30
1
THR
engineered mutation
DAB
8
1J73
A
P01308
UNP
97
8
3
THR
engineered mutation
DAB
8
1J73
C
P01308
UNP
97
8
2
anti-parallel
B
PHE
24
B
PHE
24
B
TYR
26
B
TYR
26
D
PHE
24
D
PHE
24
D
TYR
26
D
TYR
26
BINDING SITE FOR RESIDUE ZN B 31
B
ZN
31
Software
3
BINDING SITE FOR RESIDUE ZN D 31
D
ZN
31
Software
3
B
HIS
10
B
HIS
10
3
2_555
B
HIS
10
B
HIS
10
3
3_555
B
HIS
10
B
HIS
10
3
1_555
D
HIS
10
D
HIS
10
3
2_555
D
HIS
10
D
HIS
10
3
1_555
D
HIS
10
D
HIS
10
3
3_555
146
H 3